Abstract:Common genetic variants in the repressive GATA-family transcription factor (TF) TRPS1 locus are associated with breast cancer risk, and luminal breast cancer cell lines are particularly sensitive to TRPS1 knockout. We introduced an inducible degron tag into the native TRPS1 locus within a luminal breast cancer cell line to identify the direct targets of TRPS1 and determine how TRPS1 mechanistically regulates gene expression. We acutely deplete over 80 percent of TRPS1 from chromatin within 30 minutes of inducing degradation. We find that TRPS1 regulates transcription of hundreds of genes, including those related to estrogen signaling. TRPS1 directly regulates chromatin structure, which causes estrogen receptor alpha (ER) to redistribute in the genome. ER redistribution leads to both repression and activation of dozens of ER target genes. Downstream from these primary effects, TRPS1 depletion represses cell cycle-related gene sets and reduces cell doubling rate. Finally, we show that high TRPS1 activity, calculated using a gene expression signature defined by primary TRPS1-regulated genes, is associated with worse breast cancer patient prognosis. Taken together, these data suggest a model in which TRPS1 modulates the genomic distribution of ER, both activating and repressing transcription of genes related to cancer cell fitness. Breast cancer is the most common cancer among women. The majority of cases are luminal, which tend to be estrogen receptor alpha (ER)-positive. ER is well-studied among transcription factors (TFs) because it is ligand-activated. This allows for the rapid induction of ER activity and the identification of primary estrogen-responsive genes. Most TFs have not been so extensively characterized, because their activity is not so rapidly perturbable. TRPS1 is an atypical GATA family TF that is associated with corepressor complexes and transcriptional repression. Here, we use an inducible degron tag system to rapidly deplete endogenously-tagged TRPS1 in luminal breast cancer cells within 30 minutes. We find that TRPS1 directly decreases local chromatin accessibility. This decreases ER binding intensity at TRPS1-proximal ER binding sites. As an indirect effect, ER binding intensity distal to TRPS1 increases in intensity. These effects on ER binding are associated with changes in ER target gene transcription, repressing or activating these genes in concordance with the effect on ER binding intensity. Our work is consistent with a model in which TFs either exclusively activate or exclusively repress transcription of their direct target genes, with indirect primary response genes changing due to the redistribution of limiting activating TFs or coactivators.

Atypical GATA transcription factor TRPS1 represses gene expression by recruiting CHD4/NuRD(MTA2) and suppresses cell migration and invasion by repressing TP63 expression

Tricho-rhino-phalangeal syndrome 1 protein functions as a scaffold required for ubiquitin-specific protease 4-directed histone deacetylase 2 de-ubiquitination and tumor growth

A central role for TRPS1 in the control of cell cycle and cancer development.

Down-regulation of TRPS1 stimulates epithelial-mesenchymal transition and metastasis through repression of FOXA1

Transcriptional Repressor GATA Binding 1–mediated Repression of SRY-box 2 Expression Suppresses Cancer Stem Cell Functions and Tumor Initiation

Clinical significance and biological function of transcriptional repressor GATA binding 1 in gastric cancer: a study based on data mining, RT-qPCR, immunochemistry, and vitro experiment

TRPS1 drives heterochromatic origin refiring and cancer genome evolution

TRPS1 Suppresses Breast Cancer Epithelial-mesenchymal Transition Program As a Negative Regulator of SUZ12

Trps1 is Associated with the Multidrug Resistance of Lung Cancer Cell by Regulating MGMT Gene Expression.

Dysregulation of tristetraprolin and human antigen R promotes gastric cancer progressions partly by upregulation of the high-mobility group box 1

GLTSCR1 Coordinates Alternative Splicing and Transcription Elongation of ZO1 to Regulate Colorectal Cancer Progression.

The Role of Tricho-Rhino-Phalangeal Syndrome (TRPS) 1 in Apoptosis during Embryonic Development and Tumor Progression

TRPS1 modulates chromatin accessibility to regulate estrogen receptor (ER) binding and ER target gene expression in luminal breast cancer cells

TRPS1 modulates chromatin accessibility to regulate estrogen receptor alpha (ER) binding and ER target gene expression in luminal breast cancer cells

Trps1 predicts poor prognosis in advanced high grade serous ovarian carcinoma

PRMT1 accelerates cell proliferation, migration, and tumor growth by upregulating ZEB1/H4R3me2as in thyroid carcinoma

The function of TRPS1 in the development and differentiation of bone, kidney, and hair follicles

Expression of Concern: TRG-AS1 is a potent driver of oncogenicity of tongue squamous cell carcinoma through microRNA-543/Yes-associated protein 1 axis regulation

Protein arginine methyltransferase 1 interacts with Gli1 and regulates its transcriptional activity

TRPS1 maintains luminal progenitors in the mammary gland by repressing SRF/MRTF activity

Trps1 targets Ccnd1 to regulate mouse Leydig cell proliferation